Last reviewed · How we verify
NCT03448679
Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT
trial in Transplant-Related Disorder in 50 participants. Completed in 6 December 2016.
6 December 2016
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 6 December 2015 |
| Primary completion | 6 December 2016 |
| Estimated completion | 6 December 2016 |
Conditions studied
- Transplant-Related Disorder — all drugs for Transplant-Related Disorder →
Sponsor
Medical University of Vienna
Who can join
Adults 18 to 80, any sex, with Transplant-Related Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study the correlation between colloid osmotic pressure, albumin and the loss of vascular integrity in terms of endothelial dysfunction in patients with ESLD undergoing OLT and its impact on the perioperative course, as well as on morbidity and mortality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03448679
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transplant-Related Disorder
Currently open trials in the same condition.
- NCT07374874 — A Cohort Study on the Association Between the ANS Function and Acute GvHD · recruiting
- NCT07013370 — Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic H · recruiting
- NCT06066957 — Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients · Phase 2 · recruiting
- NCT06208137 — Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution. · NA · recruiting
- NCT05798286 — Quantra® System With the QPlus® Cartridge in Double-lung Transplantation · NA · active not recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03448679 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 28 February 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03448679.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing